Extracted from this filing and checked against the source text.
Debt Financings
SEC 8-K Item 2.03/2.04
confidence 0.9
ORTHOPEDIATRICS CORP incurred revolving credit of $50 million (the "Revolving Loan") with MidCap Funding IV Trust, as Agent; MidCap Financial Trust, as Term Loan Servicer; Lenders at the greater of (a) One Month Term SOFR plus 4.0% or (b) 6.50% maturing upon the earlier of December 1, 2028, or ....
- Instrument
- revolving credit
- Principal
- $50 million (the "Revolving Loan")
- Counterparty
- MidCap Funding IV Trust, as Agent; MidCap Financial Trust, as Term Loan Servicer; Lenders
- Rate
- the greater of (a) One Month Term SOFR plus 4.0% or (b) 6.50%
- Maturity
- upon the earlier of December 1, 2028, or ...
- Event
- incurrence
Exact text from the filing
a revolving loan in an aggregate principal amount that will not exceed $50 million (the "Revolving Loan")
View on SEC.gov
Debt Financings
SEC 8-K Item 2.03/2.04
confidence 0.9
ORTHOPEDIATRICS CORP incurred term loan of $30 million available in three tranches of $10 million each with MidCap Funding IV Trust, as Agent; MidCap Financial Trust, as Term Loan Servicer; Lenders at the greater of (a) One Month Term SOFR plus 6.50% or (b) 9.0% maturing the earlier of December 1, 2028, or ....
- Instrument
- term loan
- Principal
- $30 million available in three tranches of $10 million each
- Counterparty
- MidCap Funding IV Trust, as Agent; MidCap Financial Trust, as Term Loan Servicer; Lenders
- Rate
- the greater of (a) One Month Term SOFR plus 6.50% or (b) 9.0%
- Maturity
- the earlier of December 1, 2028, or ...
- Event
- incurrence
Exact text from the filing
the Lenders have provided to Borrowers a term loan in an aggregate principal amount that will not exceed $30 million available in three tranches of $10 million each subject to certain conditions (the "Term Loan")
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
ORTHOPEDIATRICS CORP terminated Squadron Loan Agreement with Squadron Capital LLC (effective 2023-12-29).
- Action
- termination
- Agreement
- credit facility
- Counterparty
- Squadron Capital LLC
- Effective
- 2023-12-29
Exact text from the filing
There was no indebtedness outstanding under the Squadron Loan Agreement and it was terminated in connection with the Credit Agreement.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
ORTHOPEDIATRICS CORP entered into Credit Agreement with MidCap Funding IV Trust, MidCap Financial Trust, and the Lenders valued at $80 million (effective 2023-12-29).
- Action
- entry
- Agreement
- credit facility
- Counterparty
- MidCap Funding IV Trust, MidCap Financial Trust, and the Lenders
- Value
- $80 million
- Effective
- 2023-12-29
Exact text from the filing
On December 29, 2023, OrthoPediatrics Corp. (the “Company”) entered into a $80 million Credit, Security and Guaranty Agreement (the “Credit Agreement”)
View on SEC.gov